Base editing the mammalian genome.

Base editing is a powerful technology that enables programmable conversion of single nucleotides in the mammalian genome. Base editors consist of a partially active Cas9 nuclease (Cas9D10A) tethered to a natural or synthetic DNA modifying enzyme. Though only recently described, BE has already shown enormous potential for basic and translational research, allowing the creation or repair of disease alleles in a variety of cell types and model organisms. In the past 2 years, a vast array of new and modified base editor variants have been described, expanding the flexibility and usefulness of the approach. Though simple in concept, effective implementation of base editing requires an understanding of the advantages and limitations of each of these tools. Here, we provide an overview of the concepts of DNA base editing, and discuss the recent progress toward the development of optimized base editing systems for mammalian cells. In addition, we highlight key technical aspects of designing and executing BE experiments, and provide detailed experimental examples of successful base editing in cell lines and organoids to help guide the effective use of these tools for genome modification.

[1]  Eugene Chung,et al.  Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy , 2018, Nature Biotechnology.

[2]  L. Lai,et al.  Highly efficient RNA-guided base editing in rabbit , 2018, Nature Communications.

[3]  David R. Liu,et al.  Base editing: precision chemistry on the genome and transcriptome of living cells , 2018, Nature Reviews Genetics.

[4]  Qiang Sun,et al.  Efficient generation of mouse models of human diseases via ABE- and BE-mediated base editing , 2018, Nature Communications.

[5]  J. Joung,et al.  High-fidelity CRISPR-Cas9 variants with undetectable genome-wide off-targets , 2015, Nature.

[6]  R. Jaenisch,et al.  One-Step Generation of Mice Carrying Reporter and Conditional Alleles by CRISPR/Cas-Mediated Genome Engineering , 2013, Cell.

[7]  Walker S. Lahr,et al.  EditR: A novel base editing quantification software using Sanger sequencing , 2017, bioRxiv.

[8]  Hao Yin,et al.  CRISPR-mediated direct mutation of cancer genes in the mouse liver , 2014, Nature.

[9]  David R. Liu,et al.  Improving the DNA specificity and applicability of base editing through protein engineering and protein delivery , 2017, Nature Communications.

[10]  Ding‐Shinn Chen,et al.  Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base Editing , 2020, Molecular therapy. Nucleic acids.

[11]  David R. Liu,et al.  Evolved Cas9 variants with broad PAM compatibility and high DNA specificity , 2018, Nature.

[12]  Joana A. Vidigal,et al.  Rapid and efficient one-step generation of paired gRNA CRISPR-Cas9 libraries , 2015, Nature Communications.

[13]  J. Keith Joung,et al.  731. High-Fidelity CRISPR-Cas9 Nucleases with No Detectable Genome-Wide Off-Target Effects , 2016 .

[14]  David R. Liu,et al.  Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage , 2016, Nature.

[15]  Lukas Villiger,et al.  Treatment of a metabolic liver disease by in vivo genome base editing in adult mice , 2018, Nature Medicine.

[16]  Jos Jonkers,et al.  Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland , 2016, Genes & development.

[17]  Nicole M. Gaudelli,et al.  Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage , 2017, Nature.

[18]  Kevin T. Zhao,et al.  Improved base excision repair inhibition and bacteriophage , 2017 .

[19]  Amanda R. Kulick,et al.  Somatic tissue engineering in mouse models reveals an actionable role for WNT pathway alterations in prostate cancer metastasis. , 2020, Cancer discovery.

[20]  P. Hsu,et al.  Methods for Optimizing CRISPR-Cas9 Genome Editing Specificity. , 2016, Molecular cell.

[21]  W. R. Thompson,et al.  Re-Evaluating One-step Generation of Mice Carrying Conditional Alleles by CRISPR-Cas9-Mediated Genome Editing Technology , 2018, bioRxiv.

[22]  Akihiko Kondo,et al.  Targeted base editing in rice and tomato using a CRISPR-Cas9 cytidine deaminase fusion , 2017, Nature Biotechnology.

[23]  Emma M Schatoff,et al.  Optimized base editors enable efficient editing in cells, organoids and mice , 2018, Nature Biotechnology.

[24]  Geng-Lin Li,et al.  Simultaneous zygotic inactivation of multiple genes in mouse through CRISPR/Cas9-mediated base editing , 2018, Development.

[25]  Gang Bao,et al.  A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human haematopoietic stem and progenitor cells , 2018, Nature Medicine.

[26]  S. Lowe,et al.  Isolation, Culture, and Maintenance of Mouse Intestinal Stem Cells. , 2016, Bio-protocol.

[27]  Shisheng Huang,et al.  Correction of the Marfan Syndrome Pathogenic FBN1 Mutation by Base Editing in Human Cells and Heterozygous Embryos , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

[28]  Nozomu Yachie,et al.  Engineered CRISPR-Cas9 nuclease with expanded targeting space , 2018, Science.

[29]  Yongsub Kim,et al.  Targeted Base Editing via RNA-Guided Cytidine Deaminases in Xenopus laevis Embryos , 2017, Molecules and cells.

[30]  Kevin T. Zhao,et al.  Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions , 2017, Nature Biotechnology.

[31]  Luca Pinello,et al.  An APOBEC3A-Cas9 base editor with minimized bystander and off-target activities , 2018, Nature Biotechnology.

[32]  Rui Zhang,et al.  Precise base editing in rice, wheat and maize with a Cas9-cytidine deaminase fusion , 2017, Nature Biotechnology.

[33]  Kiran Musunuru,et al.  In Vivo Base Editing of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) as a Therapeutic Alternative to Genome Editing , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[34]  Daesik Kim,et al.  Highly efficient RNA-guided base editing in mouse embryos , 2017, Nature Biotechnology.

[35]  Yihan Zhang,et al.  Programmable base editing of zebrafish genome using a modified CRISPR-Cas9 system , 2017, Nature Communications.

[36]  David R. Liu,et al.  Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction , 2018, Nature Biotechnology.

[37]  A. Kondo,et al.  Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems , 2016, Science.

[38]  Bianca J. Diaz,et al.  Distinct CRC-associated APC mutations dictate response to Tankyrase inhibition. , 2019, Cancer discovery.

[39]  David R. Liu,et al.  In vivo base editing of post-mitotic sensory cells , 2018, Nature Communications.

[40]  D. Avramopoulos,et al.  Modeling Psychiatric Disorder Biology with Stem Cells , 2020, Current Psychiatry Reports.

[41]  ジョン，ジェー．キース,et al.  Engineered CRISPR-Cas9 nucleases with altered PAM specificity , 2016 .